Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 10 studies | 25% ± 10% | |
smooth muscle cell | 9 studies | 19% ± 2% | |
pericyte | 8 studies | 18% ± 3% | |
neuron | 5 studies | 27% ± 14% | |
oligodendrocyte | 5 studies | 26% ± 5% | |
endothelial cell | 4 studies | 28% ± 6% | |
myofibroblast cell | 4 studies | 23% ± 5% | |
epithelial cell | 4 studies | 29% ± 12% | |
glutamatergic neuron | 4 studies | 31% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 32% ± 7% | |
pancreatic A cell | 3 studies | 31% ± 9% | |
connective tissue cell | 3 studies | 36% ± 18% | |
ciliated cell | 3 studies | 23% ± 8% | |
GABAergic neuron | 3 studies | 31% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4131.95 | 2640 / 2642 | 100% | 134.83 | 704 / 705 |
kidney | 100% | 3151.88 | 89 / 89 | 99% | 92.75 | 888 / 901 |
adrenal gland | 100% | 2955.63 | 257 / 258 | 97% | 53.60 | 223 / 230 |
breast | 100% | 3339.14 | 459 / 459 | 95% | 36.95 | 1062 / 1118 |
prostate | 100% | 3363.19 | 244 / 245 | 93% | 26.14 | 469 / 502 |
thymus | 98% | 2142.47 | 638 / 653 | 95% | 33.13 | 574 / 605 |
intestine | 100% | 5164.02 | 965 / 966 | 92% | 27.56 | 487 / 527 |
lung | 98% | 2907.00 | 569 / 578 | 91% | 25.42 | 1055 / 1155 |
uterus | 99% | 5245.52 | 169 / 170 | 89% | 35.42 | 408 / 459 |
ovary | 100% | 3485.51 | 180 / 180 | 87% | 22.38 | 372 / 430 |
esophagus | 91% | 4915.62 | 1308 / 1445 | 91% | 30.12 | 166 / 183 |
bladder | 100% | 4430.67 | 21 / 21 | 80% | 21.92 | 403 / 504 |
stomach | 86% | 2477.18 | 308 / 359 | 93% | 29.88 | 265 / 286 |
skin | 81% | 2896.96 | 1468 / 1809 | 87% | 34.96 | 411 / 472 |
pancreas | 27% | 324.84 | 89 / 328 | 97% | 41.99 | 172 / 178 |
adipose | 100% | 4167.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7879.85 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 7261.94 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 4764.96 | 850 / 861 | 0% | 0 | 0 / 0 |
spleen | 85% | 1440.22 | 206 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 18.90 | 38 / 45 |
liver | 22% | 250.23 | 50 / 226 | 39% | 9.77 | 160 / 406 |
eye | 0% | 0 | 0 / 0 | 61% | 13.27 | 49 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 10.48 | 17 / 29 |
peripheral blood | 3% | 31.31 | 27 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010467 | Biological process | gene expression |
GO_0055013 | Biological process | cardiac muscle cell development |
GO_0097084 | Biological process | vascular associated smooth muscle cell development |
GO_0009749 | Biological process | response to glucose |
GO_0007517 | Biological process | muscle organ development |
GO_0042593 | Biological process | glucose homeostasis |
GO_0044381 | Biological process | glucose import in response to insulin stimulus |
GO_0016012 | Cellular component | sarcoglycan complex |
GO_0042383 | Cellular component | sarcolemma |
GO_0005856 | Cellular component | cytoskeleton |
GO_0016010 | Cellular component | dystrophin-associated glycoprotein complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | SGCB |
Protein name | Beta-sarcoglycan Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) (A3b) Sarcoglycan beta |
Synonyms | hCG_20638 |
Description | FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. . FUNCTION: Component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. . |
Accessions | H0YA15 H0Y8J3 ENST00000514133.1 ENST00000381431.10 [Q16585-1] ENST00000506357.5 Q16585 Q5U0N0 Q6IBJ4 |